2017 ISMP Medication Safety Self Assessment for Antithrombotic Therapy in Hospitals. | AHRQ Patient Safety Network

2017 ISMP Medication Safety Self Assessment for Antithrombotic Therapy in Hospitals. | AHRQ Patient Safety Network

• Measurement Tool/Indicator
 
• Published March 2017

2017 ISMP Medication Safety Self Assessment® for Antithrombotic Therapy in Hospitals.

Horsham, PA: Institute for Safe Medication Practices; 2017.

This tool provides institutions with the capacity to assess use of antithrombotic agents, submit data to the Institution for Safe Medication Practices for self-assessment scores, compare practices with other hospitals, and allow the development of an ongoing progress report.

Available at

Related Resources

PRESS RELEASE/ANNOUNCEMENT

Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.

Federal Register. Washington, DC: Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. October 20, 2016;81:72594-72595.

JOURNAL ARTICLE › STUDY

An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm.

Olaiya A, Lurie B, Watt B, McDonald L, Greaves M, Watson HG. J Thromb Haemost. 2016;14:987-990.

NEWSPAPER/MAGAZINE ARTICLE

Common cause analysis.

Clapper C, Crea K. Patient Saf Qual Healthc. May/June 2010;7:30-35.

JOURNAL ARTICLE › STUDY

How useful are voluntary medication error reports? The case of warfarin-related medication errors.

Zhan C, Smith SR, Keyes MA, Hicks RW, Cousins DD, Clancy CM. Jt Comm J Qual Patient Saf. 2008;34:36-45.

NEWSPAPER/MAGAZINE ARTICLE

Action needed to prevent dangerous heparin-insulin confusion.

ISMP Medication Safety Alert! Acute Care Edition. May 3, 2007;12:1-2.

View More